The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Abstract
A nuclear magnetic resonance (NMR)-based method is described in which small organic molecules that bind to proximal subsites of a protein are identified, optimized, and linked together to produce high-affinity ligands. The approach is called “SAR by NMR” because structure-activity relationships (SAR) are obtained from NMR. With this technique, compounds with nanomolar affinities for the FK506 binding protein were rapidly discovered by tethering two ligands with micromolar affinities. The method reduces the amount of chemical synthesis and time required for the discovery of high-affinity ligands and appears particularly useful in target-directed drug research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy
Bodenhausen, G., & Ruben, D. J. (1980) · Chemical Physics Letters · doi:10.1016/0009-2614(80)80041-8 · Cited by 2,563
Kay, L., Keifer, P., & Saarinen, T. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00052a088 · Cited by 2,247
Gallop, M. A., Barrett, R. W., Dower, W. J., Fodor, S. P. A., & Gordon, E. M. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00035a001 · Cited by 1,135
Atomic Structure of FKBP-FK506, an Immunophilin-Immunosuppressant Complex
Van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L., & Clardy, J. (1991) · Science · doi:10.1126/science.1709302 · Cited by 635
Ribbon models of macromolecules
Carson, M. (1987) · Journal of Molecular Graphics · doi:10.1016/0263-7855(87)80010-3 · Cited by 516
[11] Multidimensional heteronuclear nuclear magnetic resonance of proteins
Marius Clore, G., & Gronenborn, A. M. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)39013-4 · Cited by 272
Eisen, M. B., Wiley, D. C., Karplus, M., & Hubbard, R. E. (1994) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340190305 · Cited by 210
Holt, D. A., Luengo, J. I., Yamashita, D. S., Oh, H. J., Konialian, A. L., Yen, H. K., Rozamus, L. W., Brandt, M., Bossard, M. J., Levy, M. A., et al. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00075a008 · Cited by 201
GroupBuild: a fragment-based method for de novo drug design
Rotstein, S. H., & Murcko, M. A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00064a003 · Cited by 192
An Experimental Approach to Mapping the Binding Surfaces of Crystalline Proteins
Allen, K. N., Bellamacina, C. R., Ding, X., Jeffery, C. J., Mattos, C., Petsko, G. A., & Ringe, D. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp952516o · Cited by 186
Atomic structure of the rapamycin human immunophilin FKBP-12 complex
Duyne, G. D. V., Standaert, R. F., Schreiber, S. L., & Clardy, J. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00019a057 · Cited by 150
Holt, D. A., Luengo, J. I., Yamashita, D. S., Oh, H.-J., Konialian-Beck, A. L., Yen, H.-K., Rozamus, L. W., Brandt, M. A., Bossard, M. J., Levy, M. A., et al. (1993) · Worldwide Protein Data Bank · doi:10.2210/pdb1fkg/pdb · Cited by 144
ATOMIC STRUCTURE OF THE RAPAMYCIN HUMAN IMMUNOPHILIN FKBP-12 COMPLEX
Duyne, G. D. V., Standaert, R. F., Schreiber, S. L., & Clardy, J. (1992) · Worldwide Protein Data Bank · doi:10.2210/pdb1fkb/pdb · Cited by 122
Meadows, R. P., Nettesheim, D. G., Xu, R. X., Olejniczak, E. T., Petros, A. M., Holzman, T. F., Severin, J. M., Gubbins, E. J., Smith, H., & Fesik, S. W. (1993) · Biochemistry · doi:10.1021/bi00054a004 · Cited by 76
Self-citationVerlinde, C. L. M. J., Rudenko, G., & Hol, W. G. J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00129424 · Cited by 71
Design and synthesis of novel FKBP inhibitors
Hauske, J. R., Dorff, P. H., Julin, S., DiBrino, J., Spencer, R. W., & Williams, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00101a005 · Cited by 31
Cited by
CHARMM: The biomolecular simulation program
Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., et al. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21287 · Cited by 8,939
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Self-citationComputational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Metadata
- Authors
- Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W.
- Venue
- Science
- Published
- 1996-11-29
- Volume
- 274
- Issue
- 5292
- Pages
- 1531-1534
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1972091733
- Cited by
- 2,041
- References
- 17
- FWCI
- 62.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.